97256 ⎘
Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
PLANT-PRODUCED mABs AGAINST CHIKUNGUNYA VIRUS WITH ENHANCED EFFECTOR FUNCTION AND EFFICACY
#2PLANT-DERIVED THERAPEUTIC MONOCLONAL ANTIBODIES AND THEIR USE IN PREGNANT WOMEN
#3IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS
#4SYNTHETIC PROMOTER FOR THE EXPRESSION OF HETEROLOGOUS PROTEINS IN PLANTS
#5IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS
#6COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS
#7TRANSGENIC PLANTS EXPRESSING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY (VHH) THAT BINDS TO A SPHINGOLIPID OF A FUNGUS
#8Method and System for Selectively Harvesting Products from Plant Cells in Culture
#9PLANT-PRODUCED mABs AGAINST CHIKUNGUNYA VIRUS WITH ENHANCED EFFECTOR FUNCTION AND EFFICACY
#10Immunomodulating transgenic plants and related methods
#11Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#12Compositions and methods for inhibiting pathogen infection
#13ORGANISMS AND METHODS FOR PRODUCING GLYCOMOLECULES WITH LOW SULFATION
#14Transient silencing of ARGONAUTE1 and ARGONAUTE4 to increase recombinant protein expression in plants
#15Immunomodulating transgenic plants and related methods
#16Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
#17Production in plants of ricin antibodies that bind to ricin B chain
#18MODIFYING N-GLYCOSYLATION OF PLANT PROTEINS USING GDP-4-DEHYDRO-6-DEOXY-D-MANNOSE REDUCTASE (RMD)
#19GEMINIVIRAL VECTOR FOR EXPRESSION OF RITUXIMAB
#20Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#21Compositions and methods for inhibiting pathogen infection
#22COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS
#23Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection
#24METHOD FOR MANUFACTURING TRANSGENIC PLANT PRODUCING IMMUNOGENIC COMPLEX PROTEINS AND IMMUNOGENIC COMPLEX PROTEINS OBTAINED THEREFROM
#25Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#26Anti-influenza antibody
#27Method of purifying monoclonal antibodies
#28Methods for producing antibodies
#29Geminiviral vector for expression of rituximab
#30Protective anti-ETEC antibody
#31Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseases
#32PRODUCTION OF SECRETED THERAPEUTIC ANTIBODIES IN MICROALGAE
#33Production of HER Receptor Antibodies in Plant
#34Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
#35Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration
#36Methods and compositions related to glycoprotein-immunoglobulin fusions
#37MONOCLONAL ANTIBODIES AGAINST CD30 LACKING IN FUCOSYL AND XYLOSYL RESIDUES
#38Therapeutic and diagnostic conjugates for use with multispecific antibodies
#39PRODUCTION OF HER RECEPTOR ANTIBODIES IN PLANT
#40Optimizing glycan processing in plants
#41Transformed soybean plant which accumulates vaccine, and use thereof
#42COMPOSITIONS AND METHODS FOR HUMANIZATION AND OPTIMIZATION OF N-GLYCANS IN PLANTS
#43HUMANIZED ANTI-CD20 ANTIBODIES AND METHODS OF USE
#44Compositions and methods for production of immunoglobulins
#45Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
#46Chimeric, human and humanized anti-CSAP monoclonal antibodies
#47Production and use of novel peptide-based agents for use with bi-specific antibodies
#48Optimizing glycan processing in plants
#49Production and use of novel peptide-based agents with bispecific antibodies
#50Production and use of novel peptide-based agents for use with bi-specific antibodies
#51MONOCLONAL ANTIBODIES AGAINST CD30 LACKING IN FUCOSYL AND XYLOSYL RESIDUES
#52System and method for production of antibodies in plant cell culture
#53GLYCAN-OPTIMIZED ANTI-CD20 ANTIBODIES
#54Production of cancer-specific antibodies in plants
#55Production and use of novel peptide-based agents for use with bi-specific antibodies
#56Chimeric, human and humanized anti-CSAp monoclonal antibodies
#57Chimeric, human and humanized anti-CSAP monoclonal antibodies
#58Chimeric, human and humanized anti-CSAp monoclonal antibodies
#59Methods of increasing polypeptide accumulation in plants
#60Method for producing immunoglobulins containing protection proteins and their use
#61Chimeric, human and humanized anti-CSAP monoclonal antibodies
#62Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants
#63Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in plants
#64SCFVS IN PHOTOSYNTHETIC MICROBES
#65Plant production of immunoglobulins with reduced fucosylation
#66Optimizing glycan processing plants
#67Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#68Production of rabies antibodies in plants
#69Production and use of novel peptide-based agents for use with bi-specific antibodies
#70Production of antibodies
#71Production of antibodies
#72Production and use of novel peptide-based agents with bispecific antibodies
#73Self antigen vaccines for treating B-cell lymphomas and other cancers
#74Recombinant single chain antibody in heterotrophic algae for pathogen control and use
#75Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
#76Transgenic plants expressing assembled secretory antibodies
#77Multimeric protein engineering
#78Method for producing immunoglobulins containing protection proteins and their use
#79Chimeric, human and humanized anti-CSAp monoclonal antibodies
#80Production of cancer-specific antibodies in plants
#81Methods of increasing polypeptide accumulation in plants
#82Method for recovering proteins from the interstitial fluid of plant tissues
#83Complex formation for the stabilisation and purification of proteins of interest
#84Immunoglobulin having particular framework scaffold and methods of making and using
#85Therapeutic and diagnostic conjugates for use with multispecific antibodies